• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Research Brief on tert-Butyl (2-Chloroethyl)carbamate (CAS: 71999-74-1) in Chemical Biology and Pharmaceutical Applications

tert-Butyl (2-Chloroethyl)carbamate (CAS: 71999-74-1) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This carbamate derivative is widely utilized as a key intermediate in the synthesis of various bioactive molecules, including anticancer agents, protease inhibitors, and other therapeutic compounds. Recent studies have highlighted its role in the development of novel drug candidates, particularly in the context of targeted therapies and prodrug design.

One of the most notable applications of tert-Butyl (2-Chloroethyl)carbamate is its use in the synthesis of nitrogen mustard derivatives, which are known for their alkylating properties and potential in cancer treatment. A 2023 study published in the *Journal of Medicinal Chemistry* demonstrated the compound's efficacy in forming stable adducts with DNA, leading to the inhibition of tumor cell proliferation. The study also emphasized the compound's relatively low toxicity profile compared to traditional alkylating agents, making it a promising candidate for further preclinical evaluation.

In addition to its anticancer potential, tert-Butyl (2-Chloroethyl)carbamate has been explored in the context of enzyme inhibition. Research published in *Bioorganic & Medicinal Chemistry Letters* (2022) revealed its utility as a scaffold for designing irreversible inhibitors of serine hydrolases, a class of enzymes implicated in various diseases, including neurodegenerative disorders and infectious diseases. The study reported that modifications to the carbamate moiety could fine-tune the selectivity and potency of these inhibitors, offering a versatile platform for drug discovery.

Another emerging area of research involves the use of tert-Butyl (2-Chloroethyl)carbamate in prodrug strategies. A recent investigation in *Molecular Pharmaceutics* (2023) showcased its application in masking the reactive chloroethyl group, thereby improving the stability and bioavailability of parent drugs. This approach has been particularly valuable in the development of orally administered chemotherapeutic agents, where controlled release and reduced side effects are critical considerations.

Despite its promising applications, challenges remain in the large-scale synthesis and purification of tert-Butyl (2-Chloroethyl)carbamate. A 2023 review in *Organic Process Research & Development* highlighted the need for optimized synthetic protocols to enhance yield and minimize byproducts. Advances in green chemistry, such as the use of catalytic methods and solvent-free conditions, are being explored to address these limitations.

In conclusion, tert-Butyl (2-Chloroethyl)carbamate (CAS: 71999-74-1) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility as an intermediate, coupled with its potential in drug design and enzyme inhibition, underscores its importance in the development of next-generation therapeutics. Future research should focus on overcoming synthetic challenges and expanding its applications in targeted drug delivery systems.

• 79513-35-2(N-Boc-ethylenediamine hydrochloride)
• 116861-31-5(N-Boc-3-Chloropropylamine)
• 118753-70-1(tert-butyl N,N-bis(2-chloroethyl)carbamate)
• 193761-47-6(Carbamic acid,(2-chloro-1-methylethyl)-, 1,1-dimethylethyl ester, (R)- (9CI))
• 6329-26-6(Ethyl 2-chloroethylcarbamate)
• 26690-80-2(Boc-NH-PEG1-OH)
• 651035-90-4((R)-tert-Butyl (1-chloro-3-hydroxypropan-2-yl)carbamate)
• 16396-05-7(Carbamic acid,(2-chloroethyl)-, isobutyl ester (8CI))
• 38267-76-4(Tert-butyl N-ethylcarbamate)
• 122451-14-3(Carbamic acid,N-(2-chloro-2-oxoethyl)-, 1,1-dimethylethyl ester)